PubMed · 16229242
[Adhesion molecules in type 2 diabetes].
Abstract
Abnormal levels some of serum soluble adhesion molecules (ICAM-1, VICAM-1, E-selectin, P-selectin, L-selectin) have been detected in type 2 diabetic patients. There is some evidence that levels of soluble adhesion molecules depend on glycemic control, disturbances of lipid metabolism, obesity and insulin resistance. There is a few of clinical data till now, which have been suggested the significance role of adhesion molecules in pathogenesis of microangiopathy and macroangiopathy in type 2 diabetics. It is possible that in some cases measurement of serum adhesion molecules may be useful for predicting, early diagnosing prophylactic and monitoring of treatment of diabetic type 2 complications. We can modify serum levels of soluble adhesion molecules by nonpharmacologic and pharmacologic treatment.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Alina Sokup. 2005. [Adhesion molecules in type 2 diabetes].. https://pubmed.ncbi.nlm.nih.gov/16229242/
Cite the original work for its findings. Save a collection to share your selection of sources.